Basic Information

Faculty

• 薬学部

Academic Degree

• 修士（農学）(京都大学)
• 博士（農学）(京都大学)

Academic Resume (Graduate Schools)

• 京都大学, 大学院農学研究科修士課程食品生物科学専攻, 修了
• 京都大学, 大学院農学研究科博士後期課程食品生物科学専攻, 修了

Academic Resume (Undergraduate School/Majors)

• 京都大学, 農学部食品生物科学科, 卒業

ID,URL

• J-Global ID

  201901000129536182

researchmap URL

• https://researchmap.jp/00103365

Research

Research Areas

• Life sciences, Molecular biology

Papers

• Medium-chain fatty acids suppress lipotoxicity-induced hepatic fibrosis via the immunomodulating receptor GPR84.

  Ryuji Ohue-Kitano; Hazuki Nonaka; Akari Nishida; Yuki Masujima; Daisuke Takahashi; Takako Ikeda; Akiharu Uwamizu; Miyako Tanaka; Motoyuki Kohjima; Miki Igarashi; Hironori Katoh; Tomohiro Tanaka; Asuka Inoue; Takayoshi Suganami; Koji Hase; Yoshihiro Ogawa; Junken Aoki; Ikuo Kimura

  JCI insight, 08 Dec. 2022, Peer-reviewed, Lead author

  
• The Impact of Low‐Viscosity Soluble Dietary Fibers on Intestinal Microenvironment and Experimental Colitis: A Possible Preventive Application of Alpha‐Cyclodextrin in Intestinal Inflammation

  Yuka Yamanouchi; Seita Chudan; Riko Ishibashi; Ryuji Ohue‐Kitano; Miyu Nishikawa; Yoshiaki Tabuchi; Ikuo Kimura; Yoshinori Nagai; Shinichi Ikushiro; Yukihiro Furusawa

  Molecular Nutrition & Food Research, Oct. 2022, Peer-reviewed

  
• Dietary Medium-Chain Triglyceride Decanoate Affects Glucose Homeostasis Through GPR84-Mediated GLP-1 Secretion in Mice

  Hazuki Nonaka; Ryuji Ohue-Kitano; Yuki Masujima; Miki Igarashi; Ikuo Kimura

  Frontiers in Nutrition, 24 Mar. 2022, Peer-reviewed, Lead author

  
• Curdlan intake changes gut microbial composition, short-chain fatty acid production, and bile acid transformation in mice

  Keita Watanabe; Mayu Yamano; Yuki Masujima; Ryuji Ohue-Kitano; Ikuo Kimura

  Biochemistry and Biophysics Reports, Sep. 2021, Peer-reviewed

  
• Differential effects of sodium-glucose cotransporter 2 inhibitor and low-carbohydrate diet on body composition and metabolic profile in obese diabetic db/db mice

  Toru Kusakabe; Shigefumi Yokota; Mika Shimizu; Takayuki Inoue; Masashi Tanaka; Ryuji Ohue-Kitano; Kazuya Muranaka; Hajime Yamakage; Hiromichi Wada; Koji Hasegawa; Noriko Satoh-Asahara

  BMJ Open Diabetes Research & Care, Sep. 2020, Peer-reviewed

  
• Maternal gut microbiota in pregnancy influences offspring metabolic phenotype in mice

  Ikuo Kimura; Junki Miyamoto; Ryuji Ohue-Kitano; Keita Watanabe; Takahiro Yamada; Masayoshi Onuki; Ryo Aoki; Yosuke Isobe; Daiji Kashihara; Daisuke Inoue; Akihiko Inaba; Yuta Takamura; Satsuki Taira; Shunsuke Kumaki; Masaki Watanabe; Masato Ito; Fumiyuki Nakagawa; Junichiro Irie; Hiroki Kakuta; Masakazu Shinohara; Ken Iwatsuki; Gozoh Tsujimoto; Hiroaki Ohno; Makoto Arita; Hiroshi Itoh; Koji Hase

  Science, 28 Feb. 2020, Peer-reviewed

  
• Free Fatty Acid Receptors in Health and Disease.

  Ikuo Kimura; Atsuhiko Ichimura; Ryuji Ohue-Kitano; Miki Igarashi

  Physiological reviews, 01 Jan. 2020, Peer-reviewed

  
• Dietary short-chain fatty acid intake improves the hepatic metabolic condition via FFAR3

  Hidenori Shimizu; Yuki Masujima; Chihiro Ushiroda; Rina Mizushima; Satsuki Taira; Ryuji Ohue-Kitano; Ikuo Kimura

  Scientific Reports, Dec. 2019, Peer-reviewed

  
• Ketone body receptor GPR43 regulates lipid metabolism under ketogenic conditions

  Junki Miyamoto; Ryuji Ohue-Kitano; Hiromi Mukouyama; Akari Nishida; Keita Watanabe; Miki Igarashi; Junichiro Irie; Gozoh Tsujimoto; Noriko Satoh-Asahara; Hiroshi Itoh; Ikuo Kimura

  Proceedings of the National Academy of Sciences, 19 Nov. 2019, Peer-reviewed, Lead author

  
• Regulation of host energy metabolism by gut microbiota-derived short-chain fatty acids

  Hidenori Shimizu; Ryuji Ohue-Kitano; Ikuo Kimura

  Glycative Stress Research, Sep. 2019, Peer-reviewed

  
• 3-(4-Hydroxy-3-methoxyphenyl)propionic Acid Produced from 4-Hydroxy-3-methoxycinnamic Acid by Gut Microbiota Improves Host Metabolic Condition in Diet-Induced Obese Mice

  Ryuji Ohue-Kitano; Satsuki Taira; Keita Watanabe; Yuki Masujima; Toru Kuboshima; Junki Miyamoto; Yosuke Nishitani; Hideaki Kawakami; Hiroshige Kuwahara; Ikuo Kimura

  Nutrients, 09 May 2019, Peer-reviewed, Lead author, Corresponding author

  
• Serum soluble TREM2 is a potential novel biomarker of cognitive impairment in Japanese non-obese patients with diabetes

  M. Tanaka; H. Yamakage; S. Masuda; T. Inoue; R. Ohue-Kitano; R. Araki; Y. Matoba; M. Saito; T. Nagaoka; K. Yonezawa; T. Tanaka; M. Suzuki; M. Sawamura; M. Nishimura; S. Odori; H. Wada; K. Kotani; T. Kusakabe; A. Shimatsu; K. Hasegawa; N. Satoh-Asahara

  Diabetes & Metabolism, Jan. 2019, Peer-reviewed

  
• Role of serum myostatin in the association between hyperinsulinemia and muscle atrophy in Japanese obese patients

  Masashi Tanaka; Shinya Masuda; Hajime Yamakage; Takayuki Inoue; Ryuji Ohue-Kitano; Shigefumi Yokota; Toru Kusakabe; Hiromichi Wada; Kiyoshi Sanada; Kojiro Ishii; Koji Hasegawa; Akira Shimatsu; Noriko Satoh-Asahara

  Diabetes Research and Clinical Practice, Aug. 2018, Peer-reviewed

  
• Chemokine (C-X-C motif) ligand 1 is a myokine induced by palmitate and is required for myogenesis in mouse satellite cells

  S. Masuda; M. Tanaka; T. Inoue; R. Ohue-Kitano; H. Yamakage; K. Muranaka; T. Kusakabe; A. Shimatsu; K. Hasegawa; N. Satoh-Asahara

  Acta Physiologica, Mar. 2018, Peer-reviewed

  
• α‐Linolenic acid‐derived metabolites from gut lactic acid bacteria induce differentiation of anti‐inflammatory M2 macrophages through G protein‐coupled receptor 40

  Ryuji Ohue‐Kitano; Yumiko Yasuoka; Tsuyoshi Goto; Nahoko Kitamura; Si‐Bum Park; Shigenobu Kishino; Ikuo Kimura; Mayu Kasubuchi; Haruya Takahashi; Yongjia Li; Yu‐Sheng Yeh; Huei‐Fen Jheng; Mari Iwase; Masashi Tanaka; Shinya Masuda; Takayuki Inoue; Hajime Yamakage; Toru Kusakabe; Fumito Tani; Akira Shimatsu; Nobuyuki Takahashi; Jun Ogawa; Noriko Satoh‐Asahara; Teruo Kawada

  The FASEB Journal, Jan. 2018, Peer-reviewed, Lead author

  
• 10‐oxo‐12(Z)‐octadecenoic acid, a linoleic acid metabolite produced by gut lactic acid bacteria, enhances energy metabolism by activation of TRPV1

  Minji Kim; Tomoya Furuzono; Kanae Yamakuni; Yongjia Li; Young‐Il Kim; Haruya Takahashi; Ryuji Ohue‐Kitano; Huei‐Fen Jheng; Nobuyuki Takahashi; Yuriko Kano; Rina Yu; Shigenobu Kishino; Jun Ogawa; Kunitoshi Uchida; Jun Yamazaki; Makoto Tominaga; Teruo Kawada; Tsuyoshi Goto

  The FASEB Journal, Nov. 2017, Peer-reviewed

  
• Prediction of functional profiles of gut microbiota from 16S rRNA metagenomic data provides a more robust evaluation of gut dysbiosis occurring in Japanese type 2 diabetic patients

  Ryo Inoue; Ryuji Ohue-Kitano; Takamitsu Tsukahara; Masashi Tanaka; Shinya Masuda; Takayuki Inoue; Hajime Yamakage; Toru Kusakabe; Koji Hasegawa; Akira Shimatsu; Noriko Satoh-Asahara

  Journal of Clinical Biochemistry and Nutrition, 2017, Peer-reviewed, Lead author

  
• Synthesized enone fatty acids resembling metabolites from gut microbiota suppress macrophage-mediated inflammation in adipocytes

  Ha-Eun Yang; Yongjia Li; Akira Nishimura; Huei-Fen Jheng; Ana Yuliana; Ryuji Kitano-Ohue; Wataru Nomura; Nobuyuki Takahashi; Chu-Sook Kim; Rina Yu; Nahoko Kitamura; Si-Bum Park; Shigenobu Kishino; Jun Ogawa; Teruo Kawada; Tsuyoshi Goto

  Molecular Nutrition & Food Research, Oct. 2017, Peer-reviewed

  
• Omega-3 polyunsaturated fatty acids suppress the inflammatory responses of lipopolysaccharide-stimulated mouse microglia by activating SIRT1 pathways

  Takayuki Inoue; Masashi Tanaka; Shinya Masuda; Ryuji Ohue-Kitano; Hajime Yamakage; Kazuya Muranaka; Hiromichi Wada; Toru Kusakabe; Akira Shimatsu; Koji Hasegawa; Noriko Satoh-Asahara

  Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, May 2017, Peer-reviewed

  
• A Novel TREM2-Mediated Link between Diabetes and Cognitive Impairment: Recent Findings and Future Perspectives

  Masashi Tanaka; Hajime Yamakage; Takayuki Inoue; Shinya Masuda; Ryuji Ohue-Kitano; Toru Kusakabe; Noriko Satoh-Asahara

  Journal of Alzheimer’s Disease & Parkinsonism, 2017, Peer-reviewed

  
• 10-oxo-12(Z)-octadecenoic acid, a linoleic acid metabolite produced by gut lactic acid bacteria, potently activates PPARγ and stimulates adipogenesis

  Tsuyoshi Goto; Young-Il Kim; Tomoya Furuzono; Nobuyuki Takahashi; Kanae Yamakuni; Ha-Eun Yang; Yongjia Li; Ryuji Ohue; Wataru Nomura; Tatsuya Sugawara; Rina Yu; Nahoko Kitamura; Si-Bum Park; Shigenobu Kishino; Jun Ogawa; Teruo Kawada

  Biochemical and Biophysical Research Communications, Apr. 2015, Peer-reviewed

  
• Changes in lamina propria dendritic cells on the oral administration of exogenous protein antigens during weaning

  Ryuji Ohue; Masahiro Nakamoto; Naofumi Kitabatake; Fumito Tani

  Cytotechnology, May 2012, Peer-reviewed, Lead author

  
• Bacterial Heat Shock Protein 60, GroEL, Can Induce the Conversion of Naïve T Cells into a CD4+ CD25+ Foxp3-Expressing Phenotype

  Ryuji Ohue; Kei Hashimoto; Masahiro Nakamoto; Yuichi Furukawa; Tetsuya Masuda; Naofumi Kitabatake; Fumito Tani

  Journal of Innate Immunity, 2011, Peer-reviewed, Lead author

  
• Effects of CpG- oligodeoxynucleotides on dendritic cell development

  R. Ohue; F. Tani; N. Kitabatake

  Nucleic Acids Symposium Series, 01 Sep. 2008, Peer-reviewed, Lead author

  

Misc.

• ケトン体の新たな受容体の発見の意義

  塩野 勝之; 北野(大植)隆司; 木村 郁夫

  循環器内科, Jul. 2022

  
• 腸内フローラ・口腔フローラ改善によるウェルネスアップ

  大植 隆司; 木村 郁夫

  食と健康, 2022, Lead author

  
• 妊娠期の腸内環境と子供の代謝

  野仲 葉月; 大植 隆司; 木村 郁夫

  糖尿病・内分泌代謝科, Jan. 2022

  
• 肥満患者における骨格筋由来液性因子・マイオスタチンを介した耐糖能悪化と骨格筋萎縮

  田中 将志; 増田 慎也; 山陰 一; 井上 隆之; 北野 隆司; 横田 繁史; 村中 和哉; 日下部 徹; 和田 啓道; 真田 樹義; 石井 好二郎; 長谷川 浩二; 島津 章; 浅原 哲子

  糖尿病, Apr. 2018

  
• ω3不飽和脂肪酸によるSIRT1経路を介したミクログリア活性抑制

  井上 隆之; 田中 将志; 増田 慎也; 山陰 一; 北野 隆司; 村中 和哉; 日下部 徹; 和田 啓道; 島津 章; 長谷川 浩二; 浅原 哲子

  肥満研究, Sep. 2017

  
• 糖尿病・肥満における新規認知症予知バイオマーカー 血清TREM2の病態意義の解明

  田中 将志; 山陰 一; 増田 慎也; 井上 隆之; 北野 隆司; 村中 和哉; 小鳥 真司; 和田 啓道; 小谷 和彦; 日下部 徹; 島津 章; 長谷川 浩二; 浅原 哲子

  日本内分泌学会雑誌, Apr. 2017

  
• マウス活性化ミクログリアにおけるω3不飽和脂肪酸によるSIRT1を介した炎症抑制作用機序の解明

  井上 隆之; 田中 将志; 増田 慎也; 山陰 一; 北野 隆司; 村中 和哉; 日下部 徹; 和田 啓道; 島津 章; 長谷川 浩二; 浅原 哲子

  日本内分泌学会雑誌, Apr. 2017

  
• ω3不飽和脂肪酸によるSIRT1を介した抗炎症作用とミクログリア活性化抑制機序の解明

  井上 隆之; 田中 将志; 増田 慎也; 山陰 一; 北野 隆司; 村中 和哉; 日下部 徹; 和田 啓道; 島津 章; 長谷川 浩二; 浅原 哲子

  糖尿病, Apr. 2017

  
• 肥満・糖尿病における認知症予知バイオマーカーの探索 血清TREM2の病態意義

  田中 将志; 山陰 一; 増田 慎也; 井上 隆之; 北野 隆司; 村中 和哉; 和田 啓道; 長谷川 浩二; 荒木 里香; 的場 ゆか; 齋藤 美穂; 長岡 匡; 米澤 一也; 田中 剛史; 大谷 すみれ; 澤村 守夫; 西村 元伸; 島津 章; 浅原 哲子

  肥満研究, Sep. 2016

  
• 活性化ミクログリアにおけるSIRT1を介したω3不飽和脂肪酸による炎症抑制作用機序の解明

  井上 隆之; 田中 将志; 増田 慎也; 山陰 一; 北野 隆司; 村中 和哉; 和田 啓道; 長谷川 浩二; 島津 章; 浅原 哲子

  肥満研究, Sep. 2016

  
• 糖尿病・肥満における新規認知症予知バイオマーカーの検討 TREM2の病態意義の解明

  田中 将志; 山陰 一; 増田 慎也; 井上 隆之; 北野 隆司; 村中 和哉; 小鳥 真司; 村瀬 永子; 大谷 良; 中村 道三; 和田 啓道; 小谷 和彦; 日下部 徹; 島津 章; 長谷川 浩二; 浅原 哲子

  肥満研究, Sep. 2017

  
• 肥満・糖尿病における新規認知症予知バイオマーカーの探索 TREM2の病態生理学的意義の解明

  田中 将志; 山陰 一; 増田 慎也; 井上 隆之; 北野 隆司; 村中 和哉; 小鳥 真司; 和田 啓道; 小谷 和彦; 日下部 徹; 島津 章; 長谷川 浩二; 浅原 哲子

  日本動脈硬化学会総会プログラム・抄録集, Jun. 2017

  
• 糖尿病における認知機能低下・認知症の発症予知バイオマーカーの探索 TREM2の病態生理学的意義の解明

  田中 将志; 山陰 一; 増田 慎也; 井上 隆之; 北野 隆司; 村中 和哉; 小鳥 真司; 和田 啓道; 小谷 和彦; 日下部 徹; 島津 章; 長谷川 浩二; 浅原 哲子

  糖尿病, Apr. 2017

  
• 内分泌・代謝疾患を診る 日本人2型糖尿病におけるPICRUSt予測メタゲノム解析を用いた腸内細菌叢プロファイルと宿主の糖代謝との関連解析

  浅原 哲子; 北野 隆司; 井上 亮; 塚原 隆充; 田中 将志; 井上 隆之; 村中 和哉; 山陰 一; 日下部 徹; 島津 章

  国立病院総合医学会講演抄録集, Nov. 2018

  
• 日本人2型糖尿病におけるPICRUSt予測メタゲノム解析を用いた腸内細菌叢プロファイルと宿主の糖代謝との機能的連関

  浅原 哲子; 北野 隆司; 井上 亮; 塚原 隆充; 田中 将志; 井上 隆之; 横田 繁史; 村中 和哉; 山陰 一; 日下部 徹; 長谷川 浩二; 島津 章

  糖尿病, Apr. 2018

  
• 日本人2型糖尿病におけるPICRUSt予測メタゲノム解析を用いた腸内細菌叢の病態生理学的意義の解明

  北野 隆司; 井上 亮; 塚原 隆充; 田中 将志; 増田 慎也; 井上 隆之; 山陰 一; 日下部 徹; 長谷川 浩二; 島津 章; 浅原 哲子

  肥満研究, Sep. 2017

  
• ケトン体受容体による生体機能制御

  大植隆司; 西田朱里; 木村郁夫

  医学のあゆみ, 2021, Lead author

  
• 腸内細菌と肥満症

  大植 隆司; 加藤 裕教; 木村 郁夫

  実験医学（増刊号）, 2021, Lead author

  
• 低炭水化物食における分子栄養メカニズム

  西田 朱里; 宮本 潤基; 大植 隆司; 木村 郁夫

  Pharma Medica, 2020

  
• 腸内細菌代謝物と生体機能—循環器・代謝疾患の治療への応用—

  清水 秀憲; 大植 隆司; 木村 郁夫

  CARDIAC PRACTICE, 2019

  
• 肥満症・2型糖尿病とプロバイオティクス

  大植隆司; 平さつき; 木村郁夫

  臨床と研究, 2018, Lead author

  
• 食物繊維由来腸内細菌代謝物、短鎖脂肪酸と宿主代謝制御

  平さつき; 渡辺啓太; 大植隆司; 木村郁夫

  ルミナコイド研究, 2018

  
• 腸内細菌と食事療法

  浅原哲子; 北野隆司

  月刊糖尿病, 2017

  
• 肥満症における腸内細菌とエクオールの関与

  浅原哲子; 北野隆司

  内分泌・糖尿病・代謝内科, 2017

  

Books and Other Publications

• 腸内微生物叢最前線

  大植 隆司; 清水 秀憲; 木村 郁夫, Joint work

  2021

  
• 食品機能性脂質の基礎と応用

  大植 隆司; 平 さつき; 木村 郁夫, Joint work

  2018

  

Awards

• 20 Nov. 2021

  松尾研究奨励賞(GPCR研究会)

External funds: Kakenhi

• ケトン体受容体を介したメタボリックシグナルに基づく新規エネルギー代謝調節機構

  Grant-in-Aid for Scientific Research (C)

  Basic Section 59040:Nutrition science and health science-related

  Kyoto University

  北野 隆司; 大植隆司

  From 01 Apr. 2020, To 31 Mar. 2023, Granted

  ケトン体;GPCR;代謝性疾患;GPCRs;エネルギー代謝;GPR109A;腸内環境

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-20K11600/
• The role of the novel sex steroid membrane receptor GPR30 on metabolic homeostasis.

  Grant-in-Aid for Early-Career Scientists

  Basic Section 38050:Food sciences-related

  Tokyo University of Agriculture and Technology

  Ryuji Ohue-Kitano

  From 01 Apr. 2018, To 31 Mar. 2020, Project Closed

  腸内細菌代謝物;エクオール;GPR30;代謝性疾患;大豆イソフラボン;臓器連関

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-18K14414/

Education

Teaching subject(s)

• From 01 Apr. 2023, To 31 Mar. 2024

  Pharmaceutical Laboratory Coaching Practice A

  8301, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2023, To 31 Mar. 2024

  Research Proposal Writing Practice B

  8403, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2023, To 31 Mar. 2024

  Research Proposal Writing Practice A

  8402, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2023, To 31 Mar. 2024

  Advanced Course of Genome Life Science

  M216, Spring, Institute for Liberal Arts and Sciences, 1
• From 01 Apr. 2023, To 31 Mar. 2024

  Advanced course of genome life sciences

  1038, Year-long, Graduate School of Biostudies, 1
• From 01 Apr. 2023, To 31 Mar. 2024

  Pharmaceutical Laboratory IV : Biochemistry and Microbiology

  C906, Fall, Faculty of Pharmaceutical Sciences, 3
• From 01 Apr. 2023, To 31 Mar. 2024

  Medicinal Frontier Science Research A

  8406, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2023, To 31 Mar. 2024

  Medicinal Frontier Science Research B

  8407, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2023, To 31 Mar. 2024

  Pharmaceutical Laboratory 4 : Biochemistry and Microbiology

  A906, Fall, Faculty of Pharmaceutical Sciences, 4
• From 01 Apr. 2023, To 31 Mar. 2024

  Seminar on Critical Reading of Scientific Papers B

  8405, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2023, To 31 Mar. 2024

  Seminar on Critical Reading of Scientific Papers A

  8404, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2022, To 31 Mar. 2023

  Pharmaceutical Laboratory IV : Biochemistry and Microbiology

  C906, Fall, Faculty of Pharmaceutical Sciences, 3
• From 01 Apr. 2022, To 31 Mar. 2023

  Pharmaceutical Laboratory Coaching Practice A

  8301, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2022, To 31 Mar. 2023

  Seminar on Critical Reading of Scientific Papers A

  8404, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2022, To 31 Mar. 2023

  Pharmaceutical Laboratory 4 : Biochemistry and Microbiology

  A906, Fall, Faculty of Pharmaceutical Sciences, 4
• From 01 Apr. 2022, To 31 Mar. 2023

  Medical Frontier Science Research A

  8406, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2022, To 31 Mar. 2023

  Research Proposal Writing Practice A

  8402, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2022, To 31 Mar. 2023

  Advanced course of genome life sciences

  1038, Year-long, Graduate School of Biostudies, 1
• From 01 Apr. 2022, To 31 Mar. 2023

  Advanced Course of Genome Life Science

  M216, Spring, Institute for Liberal Arts and Sciences, 1
• From Apr. 2021, To Mar. 2022

  Pharmaceutical Laboratory IV : Biochemistry and Microbiology

  Fall, 薬学部
• From Apr. 2021, To Mar. 2022

  Pharmaceutical Laboratory 4 : Biochemistry and Microbiology

  Fall, 薬学部